Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This algorithm, part of the company’s cloud-based platform navify Algorithm Suite, ...

Germany’s Affimed has signed a deal with Roche’s Genentech unit to develop cancer immunotherapies that activate natural killer cells, in a deal potentially worth more than $5 billion.

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

Executives at Swiss-based Roche predict the drug maker is better off than other pharmaceutical companies as it had shifted inventories to prepare for a volatile year ahead and already relies ...

Sarepta and Roche paused multiple Elevidys trials in the EU at the EMA’s request. HC Wainwright upgraded Sarepta to Neutral but sees Elevidys sales falling by Q2 2025. Learn the top momentum ...

Roche has introduced its Chest Pain Triage algorithm ... Developed in partnership with Universitätsklinikum Heidelberg, Germany, the Chest Pain Triage algorithm utilises cardiac troponin testing ...